Reproductive Solutions

Dallas, United States Founded: 2017 • Age: 9 yrs
Developer of advanced sperm collection and processing technologies. It offers solutions for at-home semen analysis and in-clinic sperm processing, improving sperm quality and increasing the chances of successful conception. The companys products are designed to enhance sperm viability during collection, transport, and preparation for various fertility treatments, including IUI, IVF, and ICSI. These technologies aim to simplify the process for both patients and healthcare providers, improving outcomes and reducing stress. The company also provides support and resources for patients and clinics.

About Reproductive Solutions

Reproductive Solutions is a company based in Dallas (United States) founded in 2017. Reproductive Solutions has raised $300 thousand across 1 funding round. Reproductive Solutions offers products and services including ProteX At-Home Semen Analysis and NovoSort Sperm Isolation Device. Reproductive Solutions operates in a competitive market with competitors including Memphasys, Cytoswim and ZyMot, among others.

  • Headquarter Dallas, United States
  • Sectors
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website rsifertility.com
  • Social LinkedIn X Facebook
  • Legal Name Reproduction Solutions Inc
Operational Areas
Key Metrics
  • Total Equity Funding
    $300K (USD)

    in 1 rounds

  • Latest Funding Round
    $300K (USD), Seed

    Jul 2020

Products & Services of Reproductive Solutions

Reproductive Solutions offers a comprehensive portfolio of products and services, including ProteX At-Home Semen Analysis and NovoSort Sperm Isolation Device.

ProteX At-Home Semen Analysis
Semen Analysis Device

Device for at-home semen collection to protect and assess sperm quality.

NovoSort Sperm Isolation Device
Sperm Processing Tool

In-cup solution for isolating motile sperm for fertility procedures.

Funding Insights of Reproductive Solutions

Reproductive Solutions has successfully raised a total of $300K through 1 strategic funding round. The most recent funding activity was a Seed round of $300 thousand completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $300,000
  • Total Rounds 1
  • Last Round Seed β€” $300,000
  • First Round $300,000

    (Jul 2020)

All 1 funding rounds of Reproductive Solutions with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2020$300,000Seed––
–

People of Reproductive Solutions

1 people are tracked at Reproductive Solutions (1 in leadership).

NameRoleGroup
Diana Peninger
CEOLeadership
Premium access

Complete people profiles for Reproductive Solutions

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Reproductive Solutions

2 dated milestones of Reproductive Solutions across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Reproductive Solutions is founded.
  2. Funding First funding round of $300K.

Competitors of Reproductive Solutions

Reproductive Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Memphasys, Cytoswim and ZyMot, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
memphasys.com2006Homebush, Australia––
Reproductive cell separation techniques for assisted reproduction are developed.
cytoswim.com2019Coventry, United Kingdom$129,3544
Sperm selection tools for assisted reproduction are developed.
zymotfertility.com2013Gaithersburg, United States––
Develops innovative sperm separation devices for medical applications.
Premium access

Detailed competitors of Reproductive Solutions

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Reproductive Solutions

Premium access

Complete news archive for Reproductive Solutions

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Reproductive Solutions

10 companies that operate in the same segment as Reproductive Solutions (Genitourinary Disorders), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapeutics for drug-resistant bacterial infections are developed.
2013Cambridge, Massachusetts, United StatesUSD 114.7 MUSD 59.62 M32
Sacral neuromodulation devices are developed for urinary and bowel control.
2013Irvine, California, United StatesUSD 143.47 M––
Provider of surgical devices for vertical hernia repair and abdominal wall reconstruction
2012Malvern, Pennsylvania, United StatesUSD 104.6 MUSD 80.28 M209
Therapeutics for infectious and autoimmune diseases are developed.
2010Cambridge, Massachusetts, United StatesUSD 470.49 M–71
Miniaturized injectable neuromodulation devices are developed for chronic diseases.
2014Santa Clara, California, United StatesUSD 123.59 M––
Developer of a therapeutic solution to treat prostate, kidney, and bladder cancer
2018Maple Grove, Minnesota, United StatesUSD 157 M–29
A device is developed to treat urinary obstruction from BPH.
2014Palo Alto, California, United StatesUSD 48 M–25
Minimally invasive devices in urology
2004Mountain View, California, United StatesUSD 137.96 M–119
Diagnostic devices for lower urinary tract diseases are developed.
2021Aliso Viejo, California, United StatesUSD 94.99 M–23
Medical device for benign prostatic hyperplasia treatment is developed.
2021Milwaukee, Wisconsin, United StatesUSD 54.16 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Reproductive Solutions

Reproductive Solutions was founded in 2017 and raised its 1st funding round 3 years after it was founded.

Reproductive Solutions is headquartered in Dallas, United States. It is registered at Dallas, Texas, United States.

Diana Peninger is the current CEO of Reproductive Solutions.

Reproductive Solutions is a funded company, having raised a total of $300K across 1 funding round to date. The company's 1st funding round was a Seed of $300K, raised on Jul 2020.

Developer of advanced sperm collection and processing technologies. It offers solutions for at-home semen analysis and in-clinic sperm processing, improving sperm quality and increasing the chances of successful conception. The companys products are designed to enhance sperm viability during collection, transport, and preparation for various fertility treatments, including IUI, IVF, and ICSI. These technologies aim to simplify the process for both patients and healthcare providers, improving outcomes and reducing stress. The company also provides support and resources for patients and clinics.

Reproductive Solutions's top competitors include Memphasys, Cytoswim and ZyMot.

Reproductive Solutions offers ProteX At-Home Semen Analysis and NovoSort Sperm Isolation Device.

Reproductive Solutions operates through Reproduction Solutions Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available